Effects of tDCS and TUS on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain
- Conditions
- Chronic PainChronic Low Back Pain
- Interventions
- Device: transcranial Direct Current Stimulation (tDCS)Device: Transcranial Ultrasound (TUS)
- Registration Number
- NCT02954432
- Lead Sponsor
- Spaulding Rehabilitation Hospital
- Brief Summary
The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain and functional limitations in subjects with NSCLBP. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 40
- Able to provide informed consent to participate in the study
- Subjects between 18 to 85 years old
- Subjects having non-specific chronic low back pain with existing pain for at least 3 months and having pain on at least half the days in the past 6 months with an average of at least 3 on a 0-10 visual analog scale (VAS) scale
- Pain resistant (partial or no response) to common analgesics and medications for chronic pain used as initial pain management such as Tylenol, Aspirin, Ibuprofen, Soma, Parafon Forte DCS, Zanaflex, and Codeine.
- Must have the ability to feel sensation by Von-Frey fiber on the forearm
- Subject is pregnant
- Contraindications to tDCS in conjunction with TUS, i.e. metallic implant in the brain or implanted brain medical devices
- History of alcohol or drug abuse within the past 6 months as self reported
- Use of carbamazepine within the past 6 months as self reported
- Suffering from severe depression (with a score of >30 in the Beck Depression Inventory)
- History of neurological disorders as self reported
- History of unexplained fainting spells as self reported
- History of severe head injury resulting in more than a momentary loss of consciousness as self reported
- History of neurosurgery as self reported
- Unstable pain
- Large placebo responder
- Low adherence during the run-in period
- Low baseline pain
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Active tDCS + Active TUS Transcranial Ultrasound (TUS) Subjects in the experimental group will undergo 20 minutes of active transcranial direct current stimulation (tDCS) and active transcranial ultrasound (TUS). Sham tDCS + Sham TUS transcranial Direct Current Stimulation (tDCS) Subjects in the sham group will undergo 20 minutes of sham transcranial direct current stimulation (tDCS) and sham transcranial ultrasound (TUS). Active tDCS + Active TUS transcranial Direct Current Stimulation (tDCS) Subjects in the experimental group will undergo 20 minutes of active transcranial direct current stimulation (tDCS) and active transcranial ultrasound (TUS). Sham tDCS + Sham TUS Transcranial Ultrasound (TUS) Subjects in the sham group will undergo 20 minutes of sham transcranial direct current stimulation (tDCS) and sham transcranial ultrasound (TUS).
- Primary Outcome Measures
Name Time Method Changes in Conditional Pain Modulation (Hand) Baseline and 3.5 months Changes in Conditional Pain Modulation (CPM) will be measured in the hand in order to determine whether anodal transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) is effective in increasing the pain pressure threshold in subjects with non-specific chronic low back pain.
Changes in Mechanical Temporal Summation (Hand) Baseline and 3.5 months Changes in Mechanical Temporal Summation (TS) from hand will be measured in order to determine whether anodal transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) is effective in reducing pain of subjects with non-specific chronic low back pain.
Changes in Pain Baseline and 3.5 months Changes in the Visual Analogue Scale (VAS) for pain will be measured in order to measure any changes in pain levels when subjects come in for sessions.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Spaulding Rehabilitation Network Research Institute
🇺🇸Cambridge, Massachusetts, United States